会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • 병아리꽃나무 추출물을 포함하는 조성물
    • 包含作为活性成分的RHODOTYPOS SCANDENS的提取物的组合物
    • KR1020120114184A
    • 2012-10-16
    • KR1020120036325
    • 2012-04-06
    • 한국생명공학연구원
    • 김원곤한백수김경심김광수김천형정회윤강영미손미진
    • A61K36/73A61K36/86A61P25/16A61P25/28
    • A61K36/73A61K36/738
    • PURPOSE: A pharmaceutical composition containing Rhodotypos scandens extract is provided to prevent or treat Parkinson's disease without side effect. CONSTITUTION: A pharmaceutical composition for preventing or treating Parkinson's disease contains Rhodotypos scandens extract as an active ingredient. The extract is prepared from stems of Rhodotypos scandens using organic solvent. The organic solvent is low carbon number alkyl alcohol of C1-C5. A functional food additive with an effect of preventing or treating Parkinson's disease contains the extract as an active ingredient. The additive is added in manufacturing foods or drinks. [Reference numerals] (AA) Cell viability (% of control); (BB) Control; (CC) 6-OHDA 50nM; (DD) Rhodotypos scandens
    • 目的:提供含有Rhodotypos scandens提取物的药物组合物,用于预防或治疗帕金森病,无副作用。 构成:用于预防或治疗帕金森病的药物组合物含有红景天甙提取物作为活性成分。 该提取物使用有机溶剂由Rhodotypos scandens的茎制备。 有机溶剂是C1-C5的低碳数烷基醇。 具有预防或治疗帕金森病作用的功能性食品添加剂含有提取物作为活性成分。 添加剂添加在制造食品或饮料中。 (附图标记)(AA)细胞活力(对照的%); (BB)控制; (CC)6-OHDA 50nM; (DD)Rhodotypos scandens
    • 5. 发明公开
    • 팥꽃나무 추출물로부터 분리된 화합물을 포함하는 신경퇴행성 질환 예방 또는 치료용 약학적 조성물
    • 用于预防或治疗包含从DAPHNE GENKWA提取物分离的化合物的神经损伤性疾病的药物组合物
    • KR1020130057878A
    • 2013-06-03
    • KR1020110123848
    • 2011-11-24
    • 한국생명공학연구원
    • 김원곤한백수김경심김광수강영미김유진김천형손미진정회윤
    • A61K31/357A61K36/83A23L1/30
    • A61K31/357A23L33/105A23V2200/322A61K36/83A61K2236/30
    • PURPOSE: A pharmaceutical composition containing genkwanine N or yuanhuacine which is isolated from a Daphne genkwa extract, or a pharmaceutically acceptable salt thereof for preventing or treating neurodegenerative diseases is provided to recover suppression of Nurr1 protein activation due to nerve damage without side effects. CONSTITUTION: A pharmaceutical composition for preventing or treating neurodegenerative diseases contains a terpenoid compound selected from a group consisting of genkwanine N and yuanhuacine, or a pharmaceutically acceptable salt thereof as an active ingredient. The neurodegenerative diseases are selected from a group consisting of Parkinson's disease(PD), Alzheimer's disease(AD), amyotrophic lateral sclerosis(ALS), Huntington's disease(HD), frontotemporal dementia, cortico basal degeneration, and progressive supranuclear palsy(PSP). Genkwanine N and yuanhuacine are derived from a Daphne genkwa extract. A pharmaceutical composition for preventing or treating diseases caused by Nurr1 functional disorder contains a terpenoid compound selected from a group consisting of genkwanine N and yuanhuacine, or a pharmaceutically acceptable salt thereof as an active ingredient.
    • 目的:提供一种从达芙妮genkwa提取物或其药学上可接受的盐分离出来的用于预防或治疗神经退行性疾病的genkwanine N或元华辛的药物组合物,用于恢复由于神经损伤引起的Nurr1蛋白激活的抑制而没有副作用。 构成:用于预防或治疗神经变性疾病的药物组合物含有选自由发明人N和元华辛组成的组的萜类化合物或其药学上可接受的盐作为活性成分。 神经变性疾病选自帕金森病(PD),阿尔茨海默氏病(AD),肌萎缩性侧索硬化(ALS),亨廷顿病(HD),额颞叶痴呆,皮层基底变性和进行性核上性麻痹(PSP)组。 Genkwanine N和元华辛衍生自达芙妮genkwa提取物。 用于预防或治疗由Nurr1功能障碍引起的疾病的药物组合物含有选自由发明人N和元华辛组成的组的萜类化合物或其药学上可接受的盐作为活性成分。
    • 8. 发明公开
    • 팥꽃나무 추출물을 포함하는 조성물
    • 包含作为活性成分的DAPHNE GENKWA的提取物的组合物
    • KR1020120113924A
    • 2012-10-16
    • KR1020110031614
    • 2011-04-06
    • 한국생명공학연구원
    • 김원곤한백수김경심김광수김천형정회윤강영미손미진
    • A61K36/83A61P25/16A61P25/24A61P25/00
    • PURPOSE: A pharmaceutical composition containing Daphne genkwa extract is provided to activate Nurr1 and to prevent or treat diseases caused by Nurr1 functional disorder. CONSTITUTION: A pharmaceutical composition for preventing or treating diseases caused by Nurr1 functional disorder contains Daphne genkwa extract as an active ingredient. The extract is prepared from stems and roots of Daphne genkwa using organic solvent. A functional food additive with an effect of preventing or treating diseases caused by Nurr1 functional disorder contains the extract as an active ingredient. The composition is administered in the form of liquid, powder, aerosol, capsule, enteric tablet, capsule, or suppository. [Reference numerals] (AA) FOLD VS DMSO; (BB) Daphne genkwa
    • 目的:提供含有Daphne genkwa提取物的药物组合物,以激活Nurr1并预防或治疗由Nurr1功能障碍引起的疾病。 构成:用于预防或治疗由Nurr1功能紊乱引起的疾病的药物组合物含有达芙妮genkwa提取物作为活性成分。 使用有机溶剂从Daphne genkwa的茎和根制备提取物。 具有预防或治疗由Nurr1功能障碍引起的疾病作用的功能性食品添加剂含有提取物作为活性成分。 组合物以液体,粉末,气溶胶,胶囊,肠溶片,胶囊或栓剂的形式施用。 (AA)FOLD VS DMSO; (BB)达芙妮genkwa